株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

徐放性注射剤

Sustained Release Injectables to 2026

発行 Greystone Research Associates 商品コード 672887
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.67円で換算しております。
Back to Top
徐放性注射剤 Sustained Release Injectables to 2026
出版日: 2019年08月06日 ページ情報: 英文
概要

当レポートでは、徐放性注射剤について調査分析し、上市製品、製剤技術、需要促進要因、市場の潜在性と課題、治療薬市場セグメント、市場影響要因など、体系的な情報を提供しています。

エグゼクティブサマリー

注射剤市場の動向

  • 自己投与傾向
  • 注射剤の製剤技術
  • 注射用デバイス設計の革新
  • 治療の需要促進要因
  • 市場要因
  • 競合情勢
  • 危険因子

徐放性製剤技術

  • 生分解性高分子
  • SR製剤技術のブランド化
  • 物理的プロセスの管理方法

徐放性注射剤 - 開発要因

  • 製剤要因
  • 安定性
  • 凍結乾燥
  • パッケージング
  • 投与要因

徐放性製品の情勢

  • アルカロイド
  • 麻酔薬
  • 抗腫瘍薬
  • GnRHアゴニスト
  • オピオイド拮抗薬
  • 合成ペプチド
  • サイトカイン
  • ホルモン
  • 抗精神病薬
  • その他

開発段階のSR注射剤

SR注射剤 - 治療薬市場の部門分析と予測

  • 依存
  • 内分泌学
  • 血糖管理
  • 感染症
  • ホルモン欠乏症
  • 代謝疾患
  • 神経学
  • 腫瘍学
  • 白血病
  • リンパ腫
  • 前立腺
  • 疼痛管理
  • リプロダクティブヘルス

企業プロファイル

目次
Product Code: SJB982

Currently approved sustained release injectables rely on a spectrum of branded formulation technologies to modulate the drug's release profile post-injection. Typically off-patent or generic drugs, they include drug therapies for almost a dozen major therapeutic segments, including neurological conditions, metabolic diseases, oncology, pain management and reproductive health. As the incidence and prevalence of chronic illnesses increases with the aging population, the attraction and interest in sustained release injectables will increase.

Sustained Release Injectables - What You Will Learn

  • What are the marketed sustained release injectable drug products, what sustained release formulation technologies are used, and who markets them?
  • What are the major factors driving sustained release injectable drug demand?
  • What sustained release injectable drug candidates are in late-stage clinical development and what is their potential impact?
  • How important are drug developer-formulation technologist relationships in the sustained release market segment, and what are the key alliances in the industry?
  • What are the essential formulation factors, delivery device selection issues, related technology factors and market development issues for sustained release injectable drug products?
  • In what therapeutic market segments do sustained release injectables compete? What is their market share today? What will it be in 2022? What is their expected growth rate?
  • What are the significant economic, technology, and regulatory factors affecting the market for sustained release injectables?

Table of Contents

Executive Summary

Injectable Drug Market Dynamics

  • The Trend toward Self-Administration
  • Injectable Drug Formulation Technology
  • Innovation in Injectable Device Designs
  • Therapeutic Demand Drivers
  • Market Factors
  • Competitive Landscape
  • Risk Factors

Sustained Release Formulation Technologies

  • Biodegradable Polymers
  • Branded SR Formulation Technologies
  • Physical Process Control Methods

Sustained Release Injectables - Development Factors

  • Formulation Factors
  • Stability
  • Lyophilization
  • Packaging
  • Administration Factors

The Sustained Release Product Landscape

  • Alkaloids
  • Anesthetics
  • Antineoplastics
  • GnRH Agonists
  • Opioid Antagonists
  • Synthetic Peptides
  • Cytokines
  • Hormones
  • Antipsychotics
  • Other Drug Classes

Development-stage SR Injectables

SR Injectables - Therapeutic Market Sector Analysis & Forecasts

  • Addiction
  • Endocrinology
  • Glycemic Control
  • Infectious Disease
  • Hormone Deficiency
  • Metabolic Diseases
  • Neurology
  • Oncology
  • Leukemia
  • Lymphoma
  • Prostate
  • Pain Management
  • Reproductive Health

Company Profiles

Back to Top